Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2004
06/03/2004WO2002061436A8 Methods and devices for quantitation of glycated protein
06/03/2004WO2002057776A8 Method of reducing particulate interference in analyte detection
06/03/2004WO1997035010A8 Chemokine alpha 2
06/03/2004US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
06/03/2004US20040107116 Networked health information system for monitoring food intake
06/03/2004US20040107074 Method and device for machine diagnosis, especially for transmission diagnosis
06/03/2004US20040107057 Enhanced protein separation and analysis
06/03/2004US20040107056 Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
06/03/2004US20040107054 Method for determining discrete quantitative structure activity relationships
06/03/2004US20040106877 Method and device for determining state of skin surface
06/03/2004US20040106855 A system and method for monitoring air flow from a person
06/03/2004US20040106806 derivatives of hydroxy-pyrene trisulphonic and disulphonic acids
06/03/2004US20040106778 Interferon gamma-like protein
06/03/2004US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
06/03/2004US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample.
06/03/2004US20040106571 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer
06/03/2004US20040106569 as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target
06/03/2004US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
06/03/2004US20040106551 Human papilloma virus immunoreactive peptides
06/03/2004US20040106541 Protein complex from ion-exchange chromatography for treatment of bacterial infections
06/03/2004US20040106538 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance
06/03/2004US20040106524 Separation mixture of drilling fluid and hydrocarbons; solvent extraction
06/03/2004US20040106215 Using immobilzed acceptors and fluorescent dyes to monitor biopolymers in fluid sample; medical diagnostics
06/03/2004US20040106214 Dry analytical element
06/03/2004US20040106213 System and method for gas discharge spectroscopy
06/03/2004US20040106212 Determining accuracy of apparatus measuring blood coagulation times: prothrombin measurement
06/03/2004US20040106210 Detection of infections in liquid samples by detecting fatty acids present in the headspace associated with the liquid sample
06/03/2004US20040106207 Determination of multi-valent metal contamination and system for removal of multi-valent metal contaminants from water
06/03/2004US20040106204 Methods for optimal usage and improved valuation of corrosive petroleum feedstocks and fractions (law521)
06/03/2004US20040106200 Whole-body optical imaging of gene expression and uses thereof
06/03/2004US20040106197 Central nerve system precursor cells inducing synaptogenic neurons in spinal cord
06/03/2004US20040106190 Flow-through assay devices
06/03/2004US20040106181 Novel isoform of human camp-dependent protein kinase, calpha -s , localizes to sperm mid-piece and the use thereof
06/03/2004US20040106179 Comprises lyases enzymatic peptide for use in screening modulator for treatment and prevention of cardiovascular disorders
06/03/2004US20040106170 Controlling fermentation; monitoring viscosity; acoustic spectrometry
06/03/2004US20040106169 System and method for metabolyte neuronal network analysis
06/03/2004US20040106168 System and method for neuronal network analysis
06/03/2004US20040106164 Analyzing microorganism associated with an enzyme in a sample water, food, soil, or a biological sample, enzyme-linked immunosorbent assay, automatic detect fluorescence with optical fiber, separate with polydimethylsiloxane films; diagnostic kits
06/03/2004US20040106162 Flexible membrane strip comprised of synthetic polymers and immobilized fluorescent moiety for detection of microorganisms in packaged food; food processing and handling; adjustment in signal pattern indicates presence of parasite
06/03/2004US20040106161 Using monoclonal antibody to prevent interaction between tyrosine kinase receptor and ligand; designing treatment for tumors; immunotherapy; antitumor agents
06/03/2004US20040106160 Screening assay for antagonists of human leukocyte receptors
06/03/2004US20040106159 Using protein fragments to induce cytokine response in CD8 and/or CD4 lymphocytes; screening mammals for previous exposure to antigens
06/03/2004US20040106158 employing as reagents a conjugate of IP3 joined at the 2-oxy through a bond or linking group to a detectable label and a truncated portion of the extracellular fragment of an IP3R
06/03/2004US20040106157 Immunological assay reagents and assay method
06/03/2004US20040106156 Methods and compositions for detecting receptor-ligand interactions in single cells
06/03/2004US20040106155 Method for kidney disease treatment by drug intervention
06/03/2004US20040106154 In vivo screen using chemical inducers of dimerization
06/03/2004US20040106153 Novel zwitterionic fluorescent dyes for labeling in proteomic and other biological analyses
06/03/2004US20040106152 Using transgenic rodents to evaluate effects of a plurality of different treatments or cosmetic compounds on tissues; drug screening; animal testing
06/03/2004US20040106151 support-bound moieties and activated supports; utility in solid phase or solution phase synthesis, biosynthesis, catalysis, purification, analysis, and identification and screening; each moiety and activated support includes activator and linker
06/03/2004US20040106150 Labeling protein with heavy nitorgen and/or carbon for comparative proteomics; evaluation of protein expression in diseased and health tissue
06/03/2004US20040106149 Novel gpcr hfrbn63
06/03/2004US20040106147 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
06/03/2004US20040106146 Immunochemical methods
06/03/2004US20040106145 Method and apparatus for the automated generation of nucleic acid ligands
06/03/2004US20040106143 Monoclonal antibody against estrogen stimulated leucine aminopeptidase
06/03/2004US20040106142 Evaluating nucleic acid sequences and identifying systemic inflammatory response syndrome
06/03/2004US20040106141 Methods and materials for examining pathways associated with glioblastoma progression
06/03/2004US20040106139 Apparatus and method for measuring activity signals of biological samples
06/03/2004US20040106136 Method for testing drug susceptibility of HIV
06/03/2004US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders
06/03/2004US20040106131 A specificity-determining substrate having a spacer interposed between the surface and a ligand to promotes homgeneous binding when forming a complex with a protein; simplification;antiaggregates; diagnosis medical
06/03/2004US20040106129 Mass spectrometric methods for biomolecular screening
06/03/2004US20040106127 Comprises nucleotide sequences coding human adult and embryonic whole brain polypeptides; microarry for genome analysis; proteomics
06/03/2004US20040106126 Sensor arrangement, device and method for testing active substances and/or active sites from a pharmacological point of view using an amperometer and/or potentiometer
06/03/2004US20040106123 Regulation of human g protein-coupled receptor
06/03/2004US20040106121 Static micro-array of biological or chemical probes immobilised on a support by magnetic attraction
06/03/2004US20040106120 Identifying nucleotide sequence changes/polymorphism associated with abnormal cell adhesion and treating skin, asthma and chronic obstruction pulmonary disease using enzyme inhibitors
06/03/2004US20040106119 Crystal structure of the mouse apoptosis-inducing factor AIF and applications of such structural data to structure-based identification, screening, or design of AIF agonists or antagonists as well as AIF fragments, mutants or variants
06/03/2004US20040106114 Preparing supports comprised of uniquely colored probed modified microspheres comprising optical bar code for use in DNA analysis
06/03/2004US20040106113 Prediction of estrogen receptor status of breast tumors using binary prediction tree modeling
06/03/2004US20040106108 Solid support assay systems and methods utilizing non-standard bases
06/03/2004US20040106106 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
06/03/2004US20040106104 Using viricide to prevent viral infection of mammalian cellscells by blocking the interaction of the viral envelope protein with one or more of the host cell receptor proteins
06/03/2004US20040106103 Novel retrovirus associated with myelodysplastic syndromers and uses thereof
06/03/2004US20040106101 System and method for quality control of a shipped neural cell culture on a microelectrode array
06/03/2004US20040106098 Using spectrum analysis to monitor and partition active pharmeceutical ingredients (API) which are highly viscous and in high concentrations; drug screening and interactions
06/03/2004US20040106097 Using disposable cartridges comprised of chip shaped carriers with active surfaces for analysis of nucleic acids contained in liquid samples
06/03/2004US20040106096 Apparatus for preserving and identifying cariogenic bacteria in bodily fluids; immunochromatography
06/03/2004US20040106095 Functional cardiomyocytes from human embryonic stem cells
06/03/2004US20040105973 Ultrasensitive non-isotopic water-soluble nanocrystals
06/03/2004US20040105868 HCV epitopes vaccines for immunization for Hepatitis C polypeptides for CD antigens
06/03/2004US20040105865 Treatment and diagnosis of prostate cancer
06/03/2004US20040105863 Method to search for male antifertility drugs based on PHGPx activity determination
06/03/2004US20040105862 Human TIMP-1 antibodies
06/03/2004US20040105861 Use of factor XIIIa inhibitors to treat atherosclerosis
06/03/2004US20040105856 Identification of compounds that modulate histamime receptors antagonist as antiinflamatory agents with DNA sequences
06/03/2004US20040105854 monoclonal or polyclonal antibodies with histidine polypeptides for immunization
06/03/2004US20040105841 Interferons, uses and compositions related thereto
06/03/2004US20040105817 Identifying therapeutic compounds based on their physical-chemical properties
06/03/2004US20040105816 Cancerous disease modifying antibodies
06/03/2004US20040105815 By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes
06/03/2004US20040105782 Multi-layer testing column
06/03/2004US20040104736 Apparatus and method for analysing fluids
06/03/2004US20040104342 Mass spectrometer
06/03/2004US20040104341 Methods and apparatus for the downhole characterization of formation fluids
06/03/2004US20040104131 Test strip includes sample chamber, working and counter electrodes, fill-detect electrodes, and auto-on conductor; data processing and storage; accuracy
06/03/2004DE202004003864U1 Glass separating vessel, for separating hydrophobic material in effluent in laboratory, has outlet sleeve for selecting different materials
06/03/2004DE10254855A1 Sensor zur Erfassung der Luftgüte und Verfahren zur Erfassung der Luftgüte mit einem Sensor Sensor for measuring air quality and method for detecting the air quality with a sensor
06/03/2004DE10254852A1 Schaltungsanordnung zur Sensorauswertung und Verfahren zur Auswertung mehrerer Sensoren Circuit arrangement for sensor evaluation and methods for evaluation of multiple sensors